Sanofi, Translate Bio in Vaccine Pact Worth Up to $2.3 Billion
(Bloomberg) -- Sanofi, the French pharmaceutical giant, is strengthening its pact with U.S. vaccine developer Translate Bio Inc. in a deal that could be valued at as much as $2.3 billion.